Indian Pharmaceutical Market soars with 9.5% growth in January 2024: Pharmarack Report Farhat Nasim20 Feb 2024 5:56 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) exhibited a robust growth of 9.5% in terms of value and 2.07% in units, reaching a total value of...
Indian Pharma Market registers 8 percent surge to Rs 17,937 Crore in January 2024: IQVIA Farhat Nasim19 Feb 2024 7:19 PM ISTNew Delhi: In an impressive kickoff to 2024, the Indian pharmaceutical market surged by 8%, reaching a substantial Rs 17,937 crore in January, as per...
Sun Pharma Gets CDSCO Panel Nod to Study Tildrakizumab Injection 100 mg/ ml Dr. Divya Colin16 Feb 2024 6:00 PM ISTNew Delhi: The drug major Sun Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Lupin unveils Bromfenac Ophthalmic Solution, 0.075% in US Ruchika Sharma14 Feb 2024 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Bromfenac Ophthalmic Solution, 0.075%, after having received an approval...
NPPA fixes retail prices of 39 formulations Roshni Dhar8 Feb 2024 5:42 PM ISTThe National Pharmaceutical Pricing Authority (NPPA) has announced that it has fixed retail prices of 39 formulations under the Drugs (Prices Control)...
Health Bulletin 08/February/2024 Roshni Dhar8 Feb 2024 4:53 PM ISTHere are the top health news for the day:NMC requires video recording of annual MBBS exams for renewal permissionsThe National Medical Commission...
NPPA fixes price for various FDCs having Sitagliptin, Linagliptin Ruchika Sharma7 Feb 2024 6:00 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has announced that it has fixed retail prices of 39 formulations under the Drugs...
Lupin bags USFDA nod for Bromfenac Ophthalmic Solution, 0.075% Ruchika Sharma7 Feb 2024 11:45 AM ISTBromfenac Ophthalmic Solution, 0.075% is indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients...
Sun Pharma reports 16.5 percent rise in net profit to Rs 2,523.8 crore in Q3 Ruchika Sharma1 Feb 2024 3:15 PM ISTMumbai: Sun Pharmaceutical Industries Ltd has reported a 16.52 per cent rise in its consolidated net profit to Rs 2,523.8 crore in the third...
CDSCO panel nod to Sun Pharma to study of anticancer drug Leuprolide acetate for depot suspension Anshika Mishra31 Jan 2024 5:41 PM ISTThe drug major Sun Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Health Bulletin 31/January/2024 Anshika Mishra31 Jan 2024 4:55 PM ISTHere are the top health news for the day:HC orders Bengal Govt to establish medical board for rape survivors' pregnancy terminationIn a significant...
Sun Pharma gets CDSCO Panel Nod To study Leuprolide acetate for depot suspension Dr. Divya Colin30 Jan 2024 6:00 PM ISTNew Delhi: The drug major Sun Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
